Obesity and NAFLD: the role of bacteria and microbiota
- PMID: 24274865
- DOI: 10.1016/j.cld.2013.09.002
Obesity and NAFLD: the role of bacteria and microbiota
Abstract
There are trillions of microorganisms in the human intestine collectively called gut microbiota. Obesity may be affected by the gut microbiota through energy harvesting and fat storage by the bacteria. Small intestinal bacterial overgrowth is also responsible for endotoxemia, systemic inflammation, and its consequences including obesity and nonalcoholic fatty liver disease (NAFLD). Relationship between gut microbiota and NAFLD is also dependent on altered choline and bile acid metabolism and endogenous alcohol production by gut bacteria. Further evidence linking gut microbiota with obesity and NAFLD comes from studies showing usefulness of probiotics in animals and patients with NAFLD. This article reviews the relationship among gut microbiota, obesity, and NAFLD.
Keywords: Endotoxemia; Intestinal permeability; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Probiotics; Small intestinal bacterial overgrowth; Toll-like receptors.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):787-93. doi: 10.1177/0148607113481623. Epub 2013 Mar 28. JPEN J Parenter Enteral Nutr. 2013. PMID: 23538296 Review.
-
Obesity, fatty liver disease and intestinal microbiota.World J Gastroenterol. 2014 Nov 28;20(44):16452-63. doi: 10.3748/wjg.v20.i44.16452. World J Gastroenterol. 2014. PMID: 25469013 Free PMC article. Review.
-
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381. World J Gastroenterol. 2014. PMID: 24966608 Free PMC article. Review.
-
Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.J Nutr Biochem. 2011 Aug;22(8):699-711. doi: 10.1016/j.jnutbio.2010.10.002. Epub 2011 Feb 2. J Nutr Biochem. 2011. PMID: 21292470 Review.
-
Gut microbiota and nonalcoholic fatty liver disease.Ann Hepatol. 2012 Jul-Aug;11(4):440-9. Ann Hepatol. 2012. PMID: 22700625 Review.
Cited by
-
The role of the gut microbiome in chronic liver disease: the clinical evidence revised.JHEP Rep. 2019 Jul 31;1(3):214-226. doi: 10.1016/j.jhepr.2019.04.004. eCollection 2019 Sep. JHEP Rep. 2019. PMID: 32039372 Free PMC article. Review.
-
The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).Mol Med. 2020 Jun 5;26(1):54. doi: 10.1186/s10020-020-00164-4. Mol Med. 2020. PMID: 32503411 Free PMC article.
-
Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review.Nutrients. 2023 Sep 14;15(18):3987. doi: 10.3390/nu15183987. Nutrients. 2023. PMID: 37764771 Free PMC article.
-
Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.World J Gastroenterol. 2016 Feb 28;22(8):2592-600. doi: 10.3748/wjg.v22.i8.2592. World J Gastroenterol. 2016. PMID: 26937147 Free PMC article.
-
In Vitro Hepatoprotective and Human Gut Microbiota Modulation of Polysaccharide-Peptides in Pleurotus citrinopileatus.Front Cell Infect Microbiol. 2022 May 20;12:892049. doi: 10.3389/fcimb.2022.892049. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35669115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical